Answers are grounded in this paper and cite their sources.
Cohort study finds prior stroke and screening results as key risks for sarcopenia persistence in end-stage kidney disease.
Our findings highlight a subgroup of ESKD patients at an elevated risk of SARC-F-defined sarcopenia persistence or development, including prior stroke and poorer baseline sarcopenia screening results.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: